www.marijuanamoment.net Open in urlscan Pro
2606:4700:e0::ac40:6018  Public Scan

URL: https://www.marijuanamoment.net/military-veterans-who-received-psychedelic-ibogaine-treatment-saw-dramatic-and-life-changing-imp...
Submission: On January 11 via manual from US — Scanned from US

Form analysis 3 forms found in the DOM

GET https://www.marijuanamoment.net/

<form method="get" id="searchform" action="https://www.marijuanamoment.net/">
  <input type="text" name="s" id="s" value="Search" onfocus="if (this.value == &quot;Search&quot;) { this.value = &quot;&quot;; }" onblur="if (this.value == &quot;&quot;) { this.value = &quot;Search&quot;; }">
  <input type="hidden" id="searchsubmit" value="Search">
</form>

POST

<form id="mc4wp-form-2" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">
    <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1705007129"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-2">
  <div class="mc4wp-response"></div>
</form>

POST

<form id="mc4wp-form-3" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">
    <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1705007129"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-3">
  <div class="mc4wp-response"></div>
</form>

Text Content

 * Politics
 * Science & Health
 * Culture
 * Business
 * Video
 * Newsletter
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter

Connect with us
 * 
 * 
 * 


MARIJUANA MOMENT

MILITARY VETERANS WHO RECEIVED PSYCHEDELIC IBOGAINE TREATMENT SAW ‘DRAMATIC’ AND
‘LIFE-CHANGING’ IMPROVEMENTS IN PTSD AND DEPRESSION, STANFORD STUDY FINDS


 * Politics
   
    * Feds Will Release Marijuana Rescheduling Memo And Related Documents ‘In
      Their Entirety’ In Response To Lawsuit
   
    * Maine Lawmakers Reject Bill To Remove Marijuana From State’s Criminal Code
      And Expunge Past Convictions
   
    * Alaska Lawmakers File Bills To Create Psychedelics Task Force To Explore
      Legalization Frameworks And Therapeutic Uses
   
    * GOP Virginia Governor Doesn’t Have ‘Any Interest’ In Legalizing Marijuana
      Sales Under New Democrat-Led Bills
   
    * Fifth Michigan City Approves Local Psychedelics Decriminalization
      Resolution

 * Science & Health
   
    * Military Veterans Who Received Psychedelic Ibogaine Treatment Saw
      ‘Dramatic’ And ‘Life-Changing’ Improvements In PTSD And Depression,
      Stanford Study Finds
   
    * Cannabis Holds Potential To Prevent And Reduce Severity Of COVID-19, While
      Treating Long-Term Symptoms, Study Finds
   
    * Medical Marijuana Is ‘Similarly Effective’ As Opioids For Treating Pain
      But With Fewer Adverse Events, Study Finds
   
    * Colleges In States That Legalize Marijuana See Spike In Applications From
      Higher Achieving Students, Study Finds
   
    * Study Finds Most Cancer Survivors Who Used Marijuana Reported ‘Great
      Degree Of Symptomatic Improvement’

 * Culture
   
    * UFC Formally Removes Marijuana From Banned Substances List For
      Professional Fighters
   
    * State Officials Promote Marijuana Gifting, Infused Baking And Safety Tips
      For The Holiday Season
   
    * States That Legalize Marijuana See Enhanced College Basketball
      Recruitment, Study Finds
   
    * Carnival Cruise Lines Denies That Anti-Marijuana Enforcement Measures Are
      Meant To Boost Alcohol Sales On Ships
   
    * SXSW Announces 2024 Lineup, Leaning Into Psychedelics While Nixing
      Cannabis Track

 * Business
   
    * Illinois Marijuana Retailers Sold $2 Billion Worth Of Legal Products In
      2023, Including A New Monthly Record In December
   
    * Connecticut Marijuana Retailers Sold $274 Million In Recreational Market’s
      First Year, With Another New Monthly Record To End 2023
   
    * New Mexico Sets New Monthly Marijuana Sales Record, With Purchases Topping
      A Half-Billion Dollars In First Full Year Of Recreational Market
   
    * Maine Sets Another Marijuana Sales Record In 2023
   
    * Mississippi Regulators Place Hold On ‘Large Number Of’ Medical Marijuana
      After Receiving Anonymous Call

 * Video
   
    * Fifth Michigan City Approves Local Psychedelics Decriminalization
      Resolution
   
    * West Virginia Senate President Says Marijuana Could Be Legalized To Help
      Curb Fentanyl Epidemic, ‘Sooner Than Later’
   
    * Wisconsin Republicans Unveil Plan To Legalize Non-Smokable Medical
      Marijuana With State-Run Dispensaries
   
    * DeSantis Says He Would ‘Respect The Decisions That States Make’ On
      Marijuana Legalization, Despite Personal Opposition
   
    * Wisconsin Governor Says He’ll ‘Absolutely’ Sign Limited GOP Medical
      Marijuana Bill, Unless It Contains ‘Poison Pills’

 * Newsletter
   
    * VA would launch legal cannabis sales in 2024 under new legislation
      (Newsletter: January 11, 2024)
   
    * Legal cannabis can combat fentanyl, WV Senate leader says (Newsletter:
      January 10, 2024)
   
    * Hawaii AG’s legal cannabis report (Newsletter: January 9, 2024)
   
    * CO gov bashes DeSantis’s cannabis stance (Newsletter: January 8, 2024)
   
    * KY gov’s cannabis expansion push (Newsletter: January 5, 2024)
   
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter




SCIENCE & HEALTH


MILITARY VETERANS WHO RECEIVED PSYCHEDELIC IBOGAINE TREATMENT SAW ‘DRAMATIC’ AND
‘LIFE-CHANGING’ IMPROVEMENTS IN PTSD AND DEPRESSION, STANFORD STUDY FINDS

Published

3 hours ago

on

January 11, 2024

By

Kyle Jaeger

Military combat veterans with traumatic brain injuries (TBI) saw “dramatic” and
“life-changing” improvements in their symptoms and cognitive functioning
immediately after receiving treatment with the psychedelic ibogaine, new
research shows.

Stanford University researchers behind the study, which was published in the
journal Nature Medicine last week, followed 30 veterans who were functionally
disabled from symptoms of TBI such as post-traumatic stress, depression and
anxiety and who had a history of repeated blast or combat exposures.

The team, which collaboration with the foundation VETS, Inc., assessed the
veterans before and after they visited a clinic in Mexico to receive ibogaine
treatment, and they identified profound changes in the participants’ mental
health, with minimal side effects.

State Governors Urge Biden to Reschedule Marijuana by Year-End for Economic and
Safety Benefits
Governors from six states are urging President Biden to fast-track the
rescheduling of marijuana from Schedule I to Schedule III, a move that could
have far-reaching economic and health implications. The governors of Colorado,
Illinois, Louisiana, Maryland, New Jersey, and New York have jointly penned a
letter to President Biden emphasizing economic benefits and aligning federal
policy with public opinion. Veuer’s Maria Mercedes Galuppo has the story.
More Videos


0 seconds of 56 secondsVolume 0%

Press shift question mark to access a list of keyboard shortcuts
Keyboard ShortcutsEnabledDisabled
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9

Next Up
A New Poll Finds That Floridians Want Legal Marijuana
00:46
facebook twitter Email pinterest
Linkhttps://cdn.jwplayer.com/previews/XfNtfaxT
Copied
Live
00:00
00:46
00:56








 

Prior to the treatment, the veterans each met the criteria for clinically
significant levels of disability. Twenty-three had diagnosable PTSD, 14 had
anxiety disorder, 15 had alcohol use disorder and 19 had been suicidal at some
point in their lifetimes.

After receiving ibogaine, in addition to magnesium to protect against potential
heart-related complications, there was an immediate “remarkable reduction” in
symptoms, “with large effect sizes” that sustained over time.



> Ibogaine “resulted in significant improvements in functioning both immediately
> and 1 month after treatment and in PTSD, depression and anxiety at 1 month
> after treatment. There were no unexpected or serious adverse events.”

After a month, the veterans’ average disability rating plummeted from 30.2 to
5.1, no longer qualifying as being disabled. They also saw an average reduction
of 88 percent in symptoms of PTSD, 87 percent in depression and 81 percent in
anxiety. Further, cognitive assessments shows improvements in “concentration,
information processing, memory and impulsivity.”



“No other drug has ever been able to alleviate the functional and
neuropsychiatric symptoms of traumatic brain injury,” Nolan Williams, an
associate professor of psychiatry and behavioral sciences at Stanford, said in a
press release. “The results are dramatic, and we intend to study this compound
further.”





The reason that the veterans had to visit Mexico is because ibogaine is
classified as a Schedule I controlled substance in the U.S., though interest in
exploring the psychedelic’s therapeutic potential has greatly expanded in recent
years.



> Ibogaine “could be a powerful therapeutic for the transdiagnostic psychiatric
> symptoms that can emerge after TBI and repeated exposure to blasts and combat,
> including suicidality.”

“These men were incredibly intelligent, high-performing individuals who
experienced life-altering functional disability from TBI during their time in
combat,” Williams said. “They were all willing to try most anything that they
thought might help them get their lives back.”

The Stanford team is planning to build on the initial findings, including
possibly incorporating brain scans to better understand how the psychedelic
affects cognition.



“In addition to treating TBI, I think this may emerge as a broader neuro-rehab
drug,” Williams said. “I think it targets a whole host of different brain areas
and can help us better understand how to treat other forms of PTSD, anxiety and
depression that aren’t necessarily linked to TBI.”

> “This is possibly the first study to report evidence for a single treatment
> with a drug that can improve chronic disability related to repeated TBI from
> combat/blast exposures.”

In response to the increased demand for research, the Drug Enforcement
Administration (DEA) has proposed a dramatic escalation in the production quota
for ibogaine and other psychedelic compounds in 2024.

In another major milestone, the U.S. Department of Veterans Affairs (VA)
recently issued a request for applications to conduct in-depth research on the
use of the psychedelics psilocybin and MDMA to treat PTSD and depression.



A recent survey of veterans and active military respondents showed that two
thirds (64 percent) supported allowing VA doctors to legally recommend
psychedelics.

In November of last year, lawmakers in a U.S. House subcommittee met for
a first-ever congressional hearing on psychedelics, with the panel focusing on
how substances like psilocybin and MDMA can aid therapy for military veterans’
facing mental health challenges.

Meanwhile, a psychedelics-focused drug development company has formally asked
the Food and Drug Administration (FDA) to review an application to approve MDMA
as a prescription medication for the treatment of PTSD after identifying
compelling results from a Phase 3 clinical trial.

> Illinois Marijuana Retailers Sold $2 Billion Worth Of Legal Products In 2023,
> Including A New Monthly Record In December





Photo courtesy of Flickr/Scamperdale.

Marijuana Moment is made possible with support from readers. If you rely on our
cannabis advocacy journalism to stay informed, please consider a monthly Patreon
pledge.
Related Topics:

Don't Miss

Cannabis Holds Potential To Prevent And Reduce Severity Of COVID-19, While
Treating Long-Term Symptoms, Study Finds

Kyle Jaeger


Kyle Jaeger is Marijuana Moment's Sacramento-based managing editor. His work has
also appeared in High Times, VICE and attn.



YOU MAY LIKE


Advertisement


MARIJUANA NEWS IN YOUR INBOX

Email address:



Leave this field empty if you're human:



SUPPORT MARIJUANA MOMENT



 * 
 * 
 * 

 * About Marijuana Moment
 * Subscribe
 * Sponsorship and Advertising
 * Privacy Policy

All the cannabis news you need, all in one place. Copyright © 2017-2024
Marijuana Moment LLC ® and Tom Angell

Information from your device can be used to personalize your ad experience.

Do not sell or share my personal information.
A Raptive Partner Site







✕
Do not sell or share my personal information.
You have chosen to opt-out of the sale or sharing of your information from this
site and any of its affiliates. To opt back in please click the "Customize my ad
experience" link.

This site collects information through the use of cookies and other tracking
tools. Cookies and these tools do not contain any information that personally
identifies a user, but personal information that would be stored about you may
be linked to the information stored in and obtained from them. This information
would be used and shared for Analytics, Ad Serving, Interest Based Advertising,
among other purposes.

For more information please visit this site's Privacy Policy.
CANCEL
CONTINUE






MARIJUANA NEWS IN YOUR INBOX

Email address:



Leave this field empty if you're human:

×